Second Circuit Revives Whistleblower’s State FCA Claims Against McKesson
- March 15, 2024
A whistleblower’s allegations that pharmaceutical distributor McKesson Corp. provided free business management tools to its customers so they would commit to purchasing drugs from the company should be allowed to go forward under various state False Claims Act (FCA) statutes even though he failed to plead a violation of the federal Anti-Kickback Statute (AKS), the Second Circuit held March 12.
ARTICLE TAGS
You must be logged in to access this content.